{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:33:08Z","timestamp":1790742788557,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1124\/jpet.124.002218","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T19:10:19Z","timestamp":1722625819000},"page":"119-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Primaquine-5,6-Orthoquinone Is Directly Hemolytic to Older G6PD Deficient RBCs in a Humanized Mouse Model"],"prefix":"10.1016","volume":"391","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8379-2004","authenticated-orcid":false,"given":"Karolina H.","family":"Dziewulska-Cronk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Reisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel M.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Nemkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca I.","family":"Cendali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Issaian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0227-9044","authenticated-orcid":false,"given":"Derek R.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitasha S.","family":"Palha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Legenzov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.Y.","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu L.","family":"Tekwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Buehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Zimring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.124.002218_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-2952(91)90005-P","volume":"41","author":"Agarwal","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.124.002218_bib2","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1016\/0006-2952(88)90327-9","article-title":"Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine enantiomers and two putative metabolites\u2013I. Effect on reduced glutathione, methemoglobin content and release of hemoglobin","volume":"37","author":"Agarwal","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.124.002218_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0969-2126(00)00104-0","article-title":"Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP(+) molecule and provides insights into enzyme deficiency","volume":"8","author":"Au","year":"2000","journal-title":"Structure"},{"key":"10.1124\/jpet.124.002218_bib4","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/0006-2952(88)90042-1","article-title":"Direct ESR detection of a free radical intermediate during the peroxidase-catalyzed oxidation of the antimalarial drug primaquine","volume":"37","author":"Augusto","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.124.002218_bib5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12936-018-2433-z","article-title":"Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry","volume":"17","author":"Avula","year":"2018","journal-title":"Malar J"},{"key":"10.1124\/jpet.124.002218_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00011-19","article-title":"8-Aminoquinoline Therapy for Latent Malaria","volume":"32","author":"Baird","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1124\/jpet.124.002218_bib7","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0006-2952(86)90145-0","article-title":"Effects of nine synthetic putative metabolites of primaquine on activity of the hexose monophosphate shunt in intact human red blood cells in vitro","volume":"35","author":"Baird","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.124.002218_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.1964.tb00692.x","article-title":"Survival of 51 Cr-Labelled Red Cells in Subjects with Thalassaemia-Trait or G6pd Deficiency or Both Abnormalities","volume":"10","author":"Bernini","year":"1964","journal-title":"Br J Haematol"},{"key":"10.1124\/jpet.124.002218_bib9","first-page":"439","article-title":"The hemolytic effect of primaquine. IV. The relationship of cell age to hemolysis","volume":"44","author":"Beutler","year":"1954","journal-title":"J Lab Clin Med"},{"key":"10.1124\/jpet.124.002218_bib10","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1124\/jpet.105.090407","article-title":"Primaquine-induced hemolytic anemia: role of splenic macrophages in the fate of 5-hydroxyprimaquine-treated rat erythrocytes","volume":"315","author":"Bowman","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002218_bib11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.105.086488","article-title":"Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine","volume":"314","author":"Bowman","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002218_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/jpet.103.062984","article-title":"Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine","volume":"309","author":"Bowman","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002218_bib13","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3181\/00379727-74-18065","article-title":"Metabolites of pamaquine in urine","volume":"74","author":"Brodie","year":"1950","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1124\/jpet.124.002218_bib14","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1038\/s41467-019-11239-0","article-title":"Antimalarial activity of primaquine operates via a two-step biochemical relay","volume":"10","author":"Camarda","year":"2019","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.124.002218_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147056","article-title":"Hematologic and systemic metabolic alterations due to Mediterranean class II G6PD deficiency in mice","volume":"6","author":"D\u2019Alessandro","year":"2021","journal-title":"JCI Insight"},{"key":"10.1124\/jpet.124.002218_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.123.001634","article-title":"Hemolysis and Metabolic Lesion of G6PD-Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model","volume":"386","author":"Dziewulska","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002218_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12936-019-2658-5","article-title":"Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes","volume":"18","author":"Fasinu","year":"2019","journal-title":"Malar J"},{"key":"10.1124\/jpet.124.002218_bib18","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/0006-2952(88)90263-8","article-title":"Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine","volume":"37","author":"Fletcher","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.124.002218_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000136189","article-title":"Alterations in normal and G-6-PD deficient human erythrocytes of various ages after exposure to metabolites of hemolytic drugs","volume":"5","author":"Fraser","year":"1971","journal-title":"Pharmacology"},{"key":"10.1124\/jpet.124.002218_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-3565(25)28010-7","article-title":"Effects of metabolites of primaquine and acetanilid on normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes","volume":"162","author":"Fraser","year":"1968","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002218_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122069","article-title":"Glucose-6-Phosphate Dehydrogenase: Update and Analysis of New Mutations around the World","volume":"17","author":"G\u00f3mez-Manzo","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.124.002218_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0022-3565(25)24263-X","article-title":"Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia","volume":"244","author":"Grossman","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002218_bib23","first-page":"50","article-title":"Hypoxic storage of murine red blood cells improves energy metabolism and post-transfusion recoveries","volume":"21","author":"Hay","year":"2022","journal-title":"Blood Transfus"},{"key":"10.1124\/jpet.124.002218_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF01703446","article-title":"Direct in vivo biotinylation of erythrocytes as an assay for red cell survival studies","volume":"63","author":"Hoffmann-Fezer","year":"1991","journal-title":"Ann Hematol"},{"key":"10.1124\/jpet.124.002218_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-0-12-407826-0.00004-7","article-title":"G6PD deficiency: global distribution, genetic variants and primaquine therapy","volume":"81","author":"Howes","year":"2013","journal-title":"Adv Parasitol"},{"key":"10.1124\/jpet.124.002218_bib26","first-page":"101","article-title":"Molecular mechanism of glucose-6-phosphate dehydrogenase deficiency","volume":"25","author":"Kahn","year":"1974","journal-title":"Humangenetik"},{"key":"10.1124\/jpet.124.002218_bib27","article-title":"Comparative metabolism and tolerability of racemic primaquine and its enantiomers in human volunteers during 7-day administration","volume":"13","author":"Khan","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.124.002218_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122510","article-title":"Quantitative determination of primaquine-5,6-ortho-quinone and carboxyprimaquine-5,6-ortho-quinone in human erythrocytes by UHPLC-MS\/MS","volume":"1163","author":"Khan","year":"2021","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/jpet.124.002218_bib29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0041-008X(85)90155-3","article-title":"Structure-activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolysates","volume":"81","author":"Link","year":"1985","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.124.002218_bib30","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood.2019000944","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"136","author":"Luzzatto","year":"2020","journal-title":"Blood"},{"key":"10.1124\/jpet.124.002218_bib31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjh.12665","article-title":"G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications","volume":"164","author":"Luzzatto","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1124\/jpet.124.002218_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101639","article-title":"Fyn specifically Regulates the activity of red cell glucose-6-phosphate-dehydrogenase","volume":"36","author":"Matt\u00e8","year":"2020","journal-title":"Redox Biol"},{"key":"10.1124\/jpet.124.002218_bib33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcmd.2012.01.001","article-title":"Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the \u201cold\u201d and update of the new mutations","volume":"48","author":"Minucci","year":"2012","journal-title":"Blood Cells Mol Dis"},{"key":"10.1124\/jpet.124.002218_bib34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijid.2023.05.063","article-title":"Short-course, high-dose primaquine regimens for the treatment of liver-stage vivax malaria in children","volume":"134","author":"Moore","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1124\/jpet.124.002218_bib35","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1073\/pnas.75.4.1979","article-title":"Biochemical mechanisms of glucose-6-phosphate dehydrogenase deficiency","volume":"75","author":"Morelli","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.124.002218_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1600-0609.1984.tb02389.x","article-title":"Mediterranean glucose 6-phosphate dehydrogenase (G6PD) deficiency\u2013near normal decay of the mutant enzyme protein in circulating erythrocytes","volume":"33","author":"Morelli","year":"1984","journal-title":"Scand J Haematol"},{"key":"10.1124\/jpet.124.002218_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4939-9236-2_2","article-title":"High-Throughput Metabolomics: Isocratic and Gradient Mass Spectrometry-Based Methods","volume":"1978","author":"Nemkov","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1124\/jpet.124.002218_bib38","first-page":"422","article-title":"Superoxide measurement as a novel probe of red blood cell storage quality","volume":"21","author":"Palha","year":"2022","journal-title":"Blood Transfus"},{"key":"10.1124\/jpet.124.002218_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24351","article-title":"An increase in urinary primaquine and a reduction in urinary primaquine-5,6-orthoquinone in the Thai population with CYP2D6 reduced enzyme function","volume":"10","author":"Pookmanee","year":"2024","journal-title":"Heliyon"},{"key":"10.1124\/jpet.124.002218_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26144357","article-title":"Simplified and Rapid Determination of Primaquine and 5,6-Orthoquinone Primaquine by UHPLC-MS\/MS: Its Application to a Pharmacokinetic Study","volume":"26","author":"Pookmanee","year":"2021","journal-title":"Molecules"},{"key":"10.1124\/jpet.124.002218_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107788","article-title":"Current investigations on clinical pharmacology and therapeutics of Glucose-6-phosphate dehydrogenase deficiency","volume":"222","author":"Ryan","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.124.002218_bib42","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/infdis\/jiz386","article-title":"Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population","volume":"220","author":"Spring","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1124\/jpet.124.002218_bib43","first-page":"413","article-title":"Metabolism of 8-aminoquinoline antimalarial agents","volume":"59","author":"Strother","year":"1981","journal-title":"Bull World Health Organ"},{"key":"10.1124\/jpet.124.002218_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12936-017-1784-1","article-title":"Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group","volume":"16","author":"Thriemer","year":"2017","journal-title":"Malar J"},{"key":"10.1124\/jpet.124.002218_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01821-21","article-title":"Measurements of 5,6-Orthoquinone, a Surrogate for the Presumed Active Primaquine Metabolite 5-Hydroxyprimaquine, in the Urine of Cambodian Adults","volume":"66","author":"Vanachayangkul","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.124.002218_bib46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/10715769009145698","article-title":"ESR detection of free radical intermediates during autoxidation of 5-hydroxyprimaquine","volume":"9","author":"V\u00e1squez-Vivar","year":"1990","journal-title":"Free Radic Res Commun"},{"key":"10.1124\/jpet.124.002218_bib47","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1016\/S0021-9258(19)50504-X","article-title":"Hydroxylated metabolites of the antimalarial drug primaquine. Oxidation and redox cycling","volume":"267","author":"V\u00e1squez-Vivar","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.124.002218_bib48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-2952(94)90022-1","article-title":"Oxidative activity of primaquine metabolites on rat erythrocytes in vitro and in vivo","volume":"47","author":"V\u00e1squez-Vivar","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.124.002218_bib49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0006-291X(77)91683-7","article-title":"NADPH-flavin reductase in human erythrocytes and the reduction of methemoglobin through flavin by the enzyme","volume":"76","author":"Yubisui","year":"1977","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.124.002218_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/trf.12264","article-title":"Strain-specific red blood cell storage, metabolism, and eicosanoid generation in a mouse model","volume":"54","author":"Zimring","year":"2014","journal-title":"Transfusion"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524177865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524177865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.124.002218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T15:36:34Z","timestamp":1739979394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524177865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0022356524177865"],"URL":"https:\/\/doi.org\/10.1124\/jpet.124.002218","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primaquine-5,6-Orthoquinone Is Directly Hemolytic to Older G6PD Deficient RBCs in a Humanized Mouse Model","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.124.002218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}